Aldeyra Therapeutics, Inc. (ALDX)
4.80
+0.15
(+3.23%)
USD |
NASDAQ |
Mar 06, 16:00
4.805
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics SG&A Expense (TTM) : 9.602M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 63.52M |
| MediciNova, Inc. | 6.159M |
| Altimmune, Inc. | 28.10M |
| AbbVie, Inc. | 14.01B |
| Actinium Pharmaceuticals, Inc. | 15.79M |